Archives
-
Instant Clot-Forming Antibacterial Dressings with Tranexamic
2026-07-08
This study introduces a bi-layer wound dressing that integrates tranexamic acid, nitric oxide donor SNAP, and propolis to address both rapid hemostasis and infection control in trauma care. The innovation demonstrates accelerated clot stabilization and potent antibacterial action, with implications for future fibrinolysis research and emergency medicine.
-
C. albicans EVs Inhibit Hyphal Growth via NRG1 Upregulation
2026-07-08
This study uncovers how high concentrations of Candida albicans extracellular vesicles (EVs) suppress hyphal development by upregulating the NRG1 transcriptional repressor. The findings clarify a self-regulatory mechanism that limits fungal pathogenicity and open new avenues for antifungal strategy development.
-
TCEP Hydrochloride: Enabling Precision in Redox Proteomics
2026-07-07
Explore how Tris(2-carboxyethyl) phosphine hydrochloride (TCEP hydrochloride) empowers advanced redox proteomics, with unique insights into structural analysis and assay design. Discover why APExBIO’s TCEP hydrochloride is pivotal for next-generation protein research.
-
Lysis Buffer in Rapid Genotyping: Protocols, Pitfalls & Prog
2026-07-07
Unlock high-integrity genomic DNA release from mouse tail tissue with APExBIO's lysis buffer—a rapid genotyping kit component engineered for reproducibility and efficiency. This article delivers workflow enhancements, troubleshooting strategies, and translational insights linking bench protocols to advanced genetic research in mouse models.
-
Phenylmethanesulfonyl Fluoride (PMSF) in Protein Extraction
2026-07-06
Phenylmethanesulfonyl fluoride (PMSF) is the gold standard for irreversible serine protease inhibition in protein extraction, safeguarding sample integrity for Western blot and cell signaling studies. Discover protocol refinements, troubleshooting insights, and translational value from recent research leveraging APExBIO’s PMSF.
-
pH-Induced Changes in Lassa Virus Spike and Antiviral Inhibi
2026-07-06
This study unveils the stepwise, pH-driven conformational transitions of the Lassa virus (LASV) spike complex during host cell entry, identifying both early and late structural events. It further elucidates the molecular mechanism by which the investigational inhibitor ARN-75039 disrupts LASV entry, providing a structural framework for antiviral development.
-
Autophagy–Metastasis Signature Enhances CRC Prognosis Precis
2026-07-05
Bai et al. (2026) developed a prognostic risk signature for colorectal cancer (CRC) by integrating autophagy- and liver metastasis-associated genes. Their comprehensive analysis, combining bulk and single-cell transcriptomic data, reveals new insights into tumor immune microenvironment remodeling and highlights potential targets for improving precision oncology strategies in CRC.
-
Mapping Metabolite Regulation of TET2 Dioxygenase: Protocol
2026-07-04
Zhang et al. present a robust, experimentally validated protocol combining biochemical assays and STD NMR spectroscopy to elucidate how metabolites regulate human TET2 dioxygenase. This framework enables systematic identification of both activators and inhibitors, deepening mechanistic understanding of metabolic-epigenetic interplay and supporting reproducible discovery in related research domains.
-
Plant Cell Lysis Buffer for WB and IP: Preserving Native Int
2026-07-03
Explore how Plant Cell Lysis Buffer for WB and IP enables high-integrity protein extraction and native interaction preservation in plant proteomics. Uncover deep scientific insights, advanced assay strategies, and practical protocol guidance distinct from existing guides.
-
Aclacinomycin A Workflows: DNA Damage and Apoptosis Precisio
2026-07-03
Aclacinomycin A (Aclarubicin) empowers researchers to model DNA damage and apoptosis with high fidelity, thanks to its dual topoisomerase inhibition and potent caspase activation. This article delivers actionable protocols, troubleshooting strategies, and a deep dive into nucleolar DNA stress, leveraging cutting-edge reference findings.
-
Artemisia argyi Oil Enhances BAT Thermogenesis to Counter Ob
2026-07-02
The referenced study demonstrates that Artemisia argyi oil (AAO) reduces high-fat diet-induced obesity by activating thermogenesis in brown adipose tissue (BAT). This mechanistic insight advances our understanding of dietary interventions for metabolic regulation and highlights BAT as a key target for functional food development.
-
Maximizing Protein Integrity for Translational OXPHOS Resear
2026-07-02
This thought-leadership article explores the mechanistic and strategic imperatives for maintaining protein integrity during advanced cancer metabolism research—particularly in studies targeting mitochondrial oxidative phosphorylation (OXPHOS) via dual-genome disruption. Drawing on recent breakthroughs in LRPPRC-targeted therapy and dasatinib synergy, it highlights how selecting the right EDTA-free protease inhibitor cocktail is pivotal for data fidelity and translational success. The article contextualizes the APExBIO Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) as an enabling tool, summarizing protocol recommendations, competitive landscape, and future directions for translational researchers.
-
Saquinavir in Translational Permeability Modeling: From HIV
2026-07-01
Explore Saquinavir as a benchmark HIV protease inhibitor and its pivotal role in next-generation drug permeability modeling. This article provides a unique, in-depth analysis of how Saquinavir bridges antiretroviral research and advanced biomimetic assay design.
-
PR-619: Broad-Spectrum Deubiquitylating Enzymes Inhibitor Pr
2026-07-01
PR-619 is a reversible, cell-permeable deubiquitylating enzymes inhibitor that enables broad interrogation of the ubiquitination pathway. It induces accumulation of ubiquitinated proteins without inhibiting proteasomal catalytic activity and is applied in cancer and neurodegenerative disease research. Quantified efficacy and solubility parameters support its use in cell-based assays.
-
TP53-Dependent DHODH Inhibition Suppresses Nasopharyngeal Ca
2026-06-30
Dong et al. reveal that targeting the pyrimidine biosynthesis enzyme DHODH with BAY2402234 induces potent antitumor effects in nasopharyngeal carcinoma (NPC) via TP53 pathway activation. This study provides a mechanistic rationale for exploiting nucleic acid metabolism vulnerabilities in NPC and highlights the importance of TP53 status for therapeutic response.